These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29115529)

  • 21. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.
    Han L; Wang W; Ding W; Zhang L
    J Cell Mol Med; 2017 Sep; 21(9):2000-2008. PubMed ID: 28266181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells.
    Bian T; Jiang D; Liu J; Yuan X; Feng J; Li Q; Zhang Q; Li X; Liu Y; Zhang J
    Biochem Biophys Res Commun; 2017 Oct; 492(3):461-467. PubMed ID: 28842254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
    Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
    Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
    Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
    Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
    Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
    Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
    Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
    Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
    Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
    Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7.
    Yan L; Ma J; Zhu Y; Zan J; Wang Z; Ling L; Li Q; Lv J; Qi S; Cao Y; Liu Y; Cao L; Zhang Y; Qi Z; Nie L
    J Cell Biochem; 2018 May; 119(5):3989-3998. PubMed ID: 29231262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
    Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
    Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
    Wang Y; Chen T; Huang H; Jiang Y; Yang L; Lin Z; He H; Liu T; Wu B; Chen J; Kamp DW; Liu G
    Oncotarget; 2017 Mar; 8(12):20133-20144. PubMed ID: 28423618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.
    Kaduthanam S; Gade S; Meister M; Brase JC; Johannes M; Dienemann H; Warth A; Schnabel PA; Herth FJ; Sültmann H; Muley T; Kuner R
    Lung Cancer; 2013 May; 80(2):223-7. PubMed ID: 23410826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines.
    Petrovic I; Milivojevic M; Popovic J; Schwirtlich M; Rankovic B; Stevanovic M
    PLoS One; 2015; 10(11):e0143591. PubMed ID: 26588701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
    Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
    Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
    Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
    Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
    Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.